Cortex makes $90M debut to chase afib with pulsed field ablation

The medtech startup incubator Ajax Health has launched a new venture for developing pulsed field ablation treatments to zap the common irregular heart rhythm known as atrial fibrillation.

Cortex will start off with $90 million in funding commitments, led by KKR and Hellman & Friedman, with backing from other investors that include AI Life Sciences, an affiliate of Access Industries.